Bristol-Myers Squibb Co. (NYSE:BMY)

CAPS Rating: 4 out of 5

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.

Results 1 - 20 of 229 : 1 2 3 4 5 6 7 8 9 10 Next »

Recs

0
Member Avatar dfm36410 (< 20) Submitted: 12/29/2015 12:01:53 PM : Outperform Start Price: $69.09 BMY Score: +4.75

Reliable .

Recs

0
Member Avatar steelers50 (25.91) Submitted: 12/24/2015 10:26:07 AM : Outperform Start Price: $67.14 BMY Score: +4.54

Best Pharm Co in the business

Recs

0
Member Avatar Bags (< 20) Submitted: 11/21/2015 10:04:39 PM : Outperform Start Price: $67.05 BMY Score: +9.10

Their product pipeline looks exciting, particularly in oncology. Also, they pay an excellent dividend, with good growth history.

Recs

0
Member Avatar KushalJ2w (< 20) Submitted: 10/6/2015 11:07:05 AM : Outperform Start Price: $59.03 BMY Score: +18.09

Consistent performance
Highly focused on R&D
Expanding footprints to other geographies

Recs

0
Member Avatar jobronze (39.08) Submitted: 7/16/2015 12:42:20 AM : Outperform Start Price: $66.80 BMY Score: +10.07

Defensive, best pick in large cap Pharma. Decent yield, incredible pipeline and new found growth focus as bio specialty

Recs

0
Member Avatar SapphireSeas (70.09) Submitted: 6/1/2015 2:29:55 PM : Outperform Start Price: $65.15 BMY Score: +13.56

A leader in cardiovascular R&D and treatments, and now coming on strong with two immunotherapy candidates - ipilimumab and nivolumab - which show tremendous promise.

Recs

0
Member Avatar andrewtraylor (42.60) Submitted: 5/8/2015 6:39:40 PM : Outperform Start Price: $65.46 BMY Score: +12.75

M.I.T.B.- Money in the Bank

Recs

0
Member Avatar hutchcraft2 (62.70) Submitted: 3/18/2015 4:32:47 PM : Outperform Start Price: $66.42 BMY Score: +10.39

Well managed with strong product line.

Recs

0
Member Avatar foolmelgoner (62.04) Submitted: 12/15/2014 8:49:32 PM : Outperform Start Price: $56.29 BMY Score: +24.33

Solid pipeline, good management

Recs

0
Member Avatar AnsgarJohn (99.30) Submitted: 11/16/2014 8:54:06 AM : Underperform Start Price: $55.74 BMY Score: -28.28

Bristol-Myers a favorite of Jima Cramer and Fools, but seems to be getting ahead of itself. PE almost 40, not much growth. End ASAP http://www.gurufocus.com/stock/BMY&summary

Recs

0
Member Avatar JeffRossMD (< 20) Submitted: 10/30/2014 12:44:24 PM : Outperform Start Price: $56.25 BMY Score: +24.59

The biotech space is just heating up as new technologies are revolutionizing cancer and chronic disease processes.

Recs

0
Member Avatar mikeayu (< 20) Submitted: 10/14/2014 7:06:01 PM : Outperform Start Price: $46.69 BMY Score: +43.15

Huge upside from cancel drugs.

Recs

0
Member Avatar afewgoodstocks14 (< 20) Submitted: 10/1/2014 2:23:35 PM : Outperform Start Price: $48.77 BMY Score: +38.42

Div. (Yield) $1.44 (2.8%)

Recs

0
Member Avatar Herbstmd (37.01) Submitted: 8/22/2014 11:55:42 AM : Outperform Start Price: $47.97 BMY Score: +46.94

Developing great new cancer drugs called PD1, which may revolutionize cancer therapy.

Recs

0
Member Avatar hydn (< 20) Submitted: 5/16/2014 10:28:57 AM : Outperform Start Price: $46.42 BMY Score: +45.15

Solid demand for ever improving products.

Recs

0
Member Avatar Johnybe (53.21) Submitted: 5/14/2014 9:46:28 PM : Outperform Start Price: $47.12 BMY Score: +43.83

strong player in this sector

Recs

0
Member Avatar DRGRNR (< 20) Submitted: 4/15/2014 7:52:17 PM : Outperform Start Price: $46.08 BMY Score: +45.39

I've owned BMY for 30 years, always a strong performer.

Recs

0
Member Avatar bassnman45 (68.09) Submitted: 1/2/2014 9:30:25 PM : Outperform Start Price: $20.14 BMY Score: +188.98

buy, hold long term and monitor

Recs

1
Member Avatar johnclanaro (< 20) Submitted: 10/28/2013 3:54:27 PM : Outperform Start Price: $48.94 BMY Score: +30.42

recent upgrade. good pipeline.

Recs

1
Member Avatar gilmomp1 (66.29) Submitted: 10/16/2013 9:38:21 PM : Outperform Start Price: $45.60 BMY Score: +37.88

I bought 100 shares of this company pre 1995 and now own 188 shares by reinvesting my dividends. Now that I'm nearing retirement that dividend looks pretty good!

Featured Broker Partners